L Nakiyingi1, H Nankabirwa, M Lamorde. 1. Department of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda ; Research Department, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala Uganda.
Abstract
BACKGROUND: The Xpert MTB/RIF test (GeneXpert) has recently been endorsed for use in resource-limited settings for the diagnosis of tuberculosis and drug resistant-tuberculosis. In resource-limited settings, GeneXpert has been used predominantly for research and there is little experience with its use in day-to-day management of patients. CASE SUMMARY: We describe a case of a 46 year old HIV-infected male with smear-negative pulmonary tuberculosis, who had several visits to various lower level health centres and two admissions in a tertiary care hospital; however, the diagnosis of tuberculosis was only made several months later on GeneXpert testing that was performed under a research project. CONCLUSION: GeneXpert facilitated identification of tuberculosis in an HIV positive patient in whom the diagnosis had been delayed when more widely available tests were used. Operational and cost-effectiveness studies are needed to provide evidence to policy makers in order to improve access to GeneXpert.
BACKGROUND: The Xpert MTB/RIF test (GeneXpert) has recently been endorsed for use in resource-limited settings for the diagnosis of tuberculosis and drug resistant-tuberculosis. In resource-limited settings, GeneXpert has been used predominantly for research and there is little experience with its use in day-to-day management of patients. CASE SUMMARY: We describe a case of a 46 year old HIV-infected male with smear-negative pulmonary tuberculosis, who had several visits to various lower level health centres and two admissions in a tertiary care hospital; however, the diagnosis of tuberculosis was only made several months later on GeneXpert testing that was performed under a research project. CONCLUSION: GeneXpert facilitated identification of tuberculosis in an HIV positive patient in whom the diagnosis had been delayed when more widely available tests were used. Operational and cost-effectiveness studies are needed to provide evidence to policy makers in order to improve access to GeneXpert.
Authors: Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland Journal: J Clin Microbiol Date: 2009-10-28 Impact factor: 5.948
Authors: Catharina C Boehme; Mark P Nicol; Pamela Nabeta; Joy S Michael; Eduardo Gotuzzo; Rasim Tahirli; Ma Tarcela Gler; Robert Blakemore; William Worodria; Christen Gray; Laurence Huang; Tatiana Caceres; Rafail Mehdiyev; Lawrence Raymond; Andrew Whitelaw; Kalaiselvan Sagadevan; Heather Alexander; Heidi Albert; Frank Cobelens; Helen Cox; David Alland; Mark D Perkins Journal: Lancet Date: 2011-04-18 Impact factor: 79.321
Authors: Andrea Rachow; Alimuddin Zumla; Norbert Heinrich; Gabriel Rojas-Ponce; Bariki Mtafya; Klaus Reither; Elias N Ntinginya; Justin O'Grady; Jim Huggett; Keertan Dheda; Catharina Boehme; Mark Perkins; Elmar Saathoff; Michael Hoelscher Journal: PLoS One Date: 2011-06-29 Impact factor: 3.240
Authors: Stephen D Lawn; Sophie V Brooks; Katharina Kranzer; Mark P Nicol; Andrew Whitelaw; Monica Vogt; Linda-Gail Bekker; Robin Wood Journal: PLoS Med Date: 2011-07-26 Impact factor: 11.069
Authors: Juliana Maria Azevedo de Lyra; Magda Maruza; Mirela Verza; Maria Madileuza Carneiro; Maria de Fátima Militão de Albuquerque; Maria Lúcia Rossetti; Ricardo Ximenes; Maria Cynthia Braga; Norma Lucena-Silva Journal: Mem Inst Oswaldo Cruz Date: 2014-08-29 Impact factor: 2.743
Authors: Edgar Kigozi; George W Kasule; Kenneth Musisi; Deus Lukoye; Samuel Kyobe; Fred Ashaba Katabazi; Eddie M Wampande; Moses L Joloba; David Patrick Kateete Journal: PLoS One Date: 2018-05-30 Impact factor: 3.240
Authors: Lydia Nakiyingi; Bareng A S Nonyane; Willy Ssengooba; Bruce J Kirenga; Damalie Nakanjako; Gloria Lubega; Pauline Byakika-Kibwika; Moses L Joloba; Jerry J Ellner; Susan E Dorman; Harriet Mayanja-Kizza; Yukari C Manabe Journal: PLoS One Date: 2015-07-29 Impact factor: 3.240
Authors: Zaiyad G Habib; Farouq M Dayyab; Abdallah Sanda; Sirajo H Tambuwal; Mahmood M Dalhat; Hamza Muhammad; Garba Iliyasu; Ibrahim Nashabaru; Abdulrazaq G Habib Journal: Case Rep Infect Dis Date: 2015-08-03